AstroNova (NASDAQ:ALOT) Rating Lowered to Sell at Zacks Investment Research

AstroNova (NASDAQ:ALOT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, reports.

According to Zacks, “AstroNova, Inc. provides data visualization technologies. The company designs, manufactures, distributes and services products which acquire, store, analyze and present data in multiple formats. The Product Identification segment offers hardware and software products and associated consumables. Test and Measurement segment includes suite of products and services which acquire and record electronic signal data from local and networked sensors. Its brand includes QuickLabel(R). AstroNova, Inc., formerly known as Astro-Med, Inc., is based in WEST WARWICK, United States. “

ALOT has been the subject of a number of other research reports. TheStreet cut shares of AstroNova from a “b-” rating to a “c+” rating in a research report on Tuesday, October 29th. ValuEngine upgraded shares of AstroNova from a “hold” rating to a “buy” rating in a research note on Wednesday, August 28th.

ALOT stock traded up $0.04 during trading on Monday, hitting $14.18. 402 shares of the company’s stock traded hands, compared to its average volume of 30,110. The firm has a market capitalization of $99.68 million, a P/E ratio of 17.29, a PEG ratio of 2.22 and a beta of 0.33. The company has a quick ratio of 1.05, a current ratio of 2.42 and a debt-to-equity ratio of 0.16. AstroNova has a 1 year low of $13.75 and a 1 year high of $27.96. The business has a fifty day simple moving average of $15.76 and a two-hundred day simple moving average of $20.26.

AstroNova (NASDAQ:ALOT) last released its quarterly earnings results on Wednesday, December 4th. The business services provider reported $0.06 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.11). AstroNova had a net margin of 3.86% and a return on equity of 7.70%. The firm had revenue of $33.32 million for the quarter. On average, equities research analysts predict that AstroNova will post 0.53 EPS for the current fiscal year.

In related news, Director Richard S. Warzala bought 2,000 shares of the company’s stock in a transaction on Friday, September 13th. The shares were bought at an average price of $16.53 per share, with a total value of $33,060.00. Following the transaction, the director now owns 9,496 shares in the company, valued at $156,968.88. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 7.80% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Strs Ohio purchased a new position in shares of AstroNova during the second quarter worth $312,000. Cavalier Investments LLC purchased a new position in AstroNova during the second quarter worth approximately $41,000. Municipal Employees Retirement System of Michigan acquired a new stake in AstroNova in the second quarter valued at approximately $425,000. Wedge Capital Management L L P NC acquired a new stake in AstroNova in the second quarter valued at approximately $650,000. Finally, Wells Fargo & Company MN increased its position in shares of AstroNova by 7.3% in the second quarter. Wells Fargo & Company MN now owns 6,992 shares of the business services provider’s stock valued at $180,000 after buying an additional 474 shares in the last quarter. 62.08% of the stock is owned by institutional investors.

AstroNova Company Profile

AstroNova, Inc designs, develops, manufactures, and distributes specialty printers, and data acquisition and analysis systems in the United States, Canada, Asia, Europe, Central and South America, and internationally. The company operates through two segments, Product Identification and Test & Measurement (T&M).

Featured Story: Understanding Options Trading

Get a free copy of the Zacks research report on AstroNova (ALOT)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for AstroNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstroNova and related companies with's FREE daily email newsletter.